Analysis of cancer-related immune suppressor mechanisms in mice
$896,773ZIAFY2015CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 38328040Paper 38192537Paper 37770128Paper 35378172Paper 35198900Paper 34033968Paper 33490900Paper 33323397Paper 33010248Paper 30414862Paper 29959458Paper 29904153Paper 29798856Paper 29795111Paper 28167218Paper 27728804Paper 26934227Paper 26133122Paper 25833323Paper 25637366Paper 25616156Paper 25401795Paper 25274062Paper 24810636Paper 23796475Paper 23077247Paper 23017136
Abstract
It has been shown that tumors have developed numerous ways to escape tumor specific immune responses. These mechanisms will ultimately not only enhance tumor growth, but also impair the effect of immune based therapies in cancer. Myeloid derived suppressor cells represent a recently identified cell population, which has been shown to impair tumor specific immune responses both in mice and human. MDSC can be divided in two subtypes (namely monocytic and granulocytic MDSC. We have been able to examine and define the regulation and function of murine MDSC by IFN-gamma and studied MDSC in different liver tumor models, models of liver inflammation and in response to anti-CD40 treatment.
View original record on NIH RePORTER →